Abstract
Dengue disease is as a global health problem. The treatment is only supportive based on presenting symptoms. To date, there is no licensed prophylactic vaccine and no specific antiviral drugs available. The study of the interactions between virus and host cell proteins will provide a better understanding of how viruses replicate and cause disease. Here, we focus on the current knowledge about the cellular proteins involved during DENV infection in different target cells in the two hosts, mosquito and human.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
